Blood viscometer market seen reaching $2.29B by 2030

The Business Research Company says the blood viscometer market is on track to grow from $1.77 billion in 2025 to $2.29 billion by 2030, fueled by rising cardiovascular disease rates, broader diagnostic testing and more automated lab workflows. North America led the market in 2025, while digital and point-of-care blood viscosity tools are expected to gain traction.

Why it matters: - Blood viscometers help clinicians measure blood viscosity, which can support diagnosis and monitoring of cardiovascular disease, diabetes and other blood-flow disorders. - The market’s growth points to rising demand for tools that can detect disease earlier and support precision diagnostics. - Blood viscosity testing is becoming more relevant as health systems expand lab automation and portable testing.

What happened: - The Business Research Company released a blood viscometer market intelligence report on July 29, 2026. - The report says the market will grow from $1.77 billion in 2025 to $1.86 billion in 2026, a 5.4% CAGR. - The market is projected to reach $2.29 billion by 2030, at a 5.3% CAGR. - North America was the largest regional market in 2025.

The details: - The report links recent market growth to rising cardiovascular disease, broader use of viscosity testing in diabetes management, more clinical diagnostic labs, laboratory automation and deeper research into blood rheology. - The report cites rising demand for early disease detection tools, more investment in precision diagnostics, wider use of portable diagnostic technologies, growth in personalized medicine and more clinical research on blood flow disorders as drivers through 2030. - The report expects stronger adoption of digital blood viscosity measurement devices. - The report also flags growing demand for point-of-care hemorheology testing. - Other anticipated trends include automated diagnostic platforms, more research-grade viscometers for clinical studies and more high-precision blood flow analysis. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, a company scoring matrix, Excel forecasting dashboards, market-hotspot infographics and updated graphics and tables. - The report provides a free sample and the full market report through the company’s sample page and the full report.

Between the lines: - The report frames blood viscometers as part of a broader shift toward earlier diagnosis and more personalized care. - The mix of lab automation, portable devices and point-of-care testing suggests buyers are looking for faster workflows and more flexible testing environments. - The emphasis on cardiovascular disease reflects the market’s dependence on chronic disease trends rather than a narrow device replacement cycle.

What's next: - The report expects continued market expansion through 2030 as precision diagnostics, portable tools and blood-flow research gain momentum. - Digital measurement devices and automated platforms are likely to shape competitive positioning in the category. - The company is also promoting direct access to its analysts and updated 2026 market intelligence products.

The bottom line: - Blood viscometer demand is rising alongside chronic disease burden and diagnostic modernization, with North America leading today and technology-driven testing formats shaping the next growth phase.